Cholesterol may be key to new therapies for Alzheimer’s disease, diabetes
Stroke care declined globally during COVID-19 pandemic despite stroke-related COVID complications
25 March 2021FDA panel rejects Pfizer’s arthritis drug as too risky
25 March 2021Cholesterol may be key to new therapies for Alzheimer’s disease, diabetes
A University of Arizona Health Sciences researcher examined the role of cholesterol in both Alzheimer’s disease and Type 2 diabetes to identify a small molecule that may help regulate cholesterol levels in the brain, making it a potential new therapeutic target for Alzheimer’s disease.
